TN2009000512A1 - Modifying glycoprotein production in plants - Google Patents
Modifying glycoprotein production in plantsInfo
- Publication number
- TN2009000512A1 TN2009000512A1 TNP2009000512A TN2009000512A TN2009000512A1 TN 2009000512 A1 TN2009000512 A1 TN 2009000512A1 TN P2009000512 A TNP2009000512 A TN P2009000512A TN 2009000512 A TN2009000512 A TN 2009000512A TN 2009000512 A1 TN2009000512 A1 TN 2009000512A1
- Authority
- TN
- Tunisia
- Prior art keywords
- plant
- nucleotide sequence
- protein
- interest
- plants
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 5
- 125000003729 nucleotide group Chemical group 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 230000004988 N-glycosylation Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 abstract 1
- 108010056664 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 230000005021 gait Effects 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Cultivation Of Plants (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94434407P | 2007-06-15 | 2007-06-15 | |
| PCT/CA2008/001139 WO2008151440A1 (fr) | 2007-06-15 | 2008-06-13 | Modification de la production de glycoprotéine dans des plantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2009000512A1 true TN2009000512A1 (en) | 2011-03-31 |
Family
ID=40129187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2009000512A TN2009000512A1 (en) | 2007-06-15 | 2009-12-10 | Modifying glycoprotein production in plants |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20110008837A1 (fr) |
| EP (1) | EP2155880B1 (fr) |
| JP (1) | JP5783720B2 (fr) |
| KR (2) | KR101385050B1 (fr) |
| CN (3) | CN104962579A (fr) |
| AU (1) | AU2008261527C1 (fr) |
| BR (1) | BRPI0812538B1 (fr) |
| CA (2) | CA2795379A1 (fr) |
| DK (1) | DK2155880T3 (fr) |
| EG (1) | EG26600A (fr) |
| ES (1) | ES2624776T3 (fr) |
| HU (1) | HUE031698T2 (fr) |
| IL (1) | IL202568A (fr) |
| MA (1) | MA31516B1 (fr) |
| MX (1) | MX2009013665A (fr) |
| NZ (2) | NZ598417A (fr) |
| PL (1) | PL2155880T3 (fr) |
| PT (1) | PT2155880T (fr) |
| RU (2) | RU2499053C2 (fr) |
| SG (1) | SG185249A1 (fr) |
| SI (1) | SI2155880T1 (fr) |
| TN (1) | TN2009000512A1 (fr) |
| WO (1) | WO2008151440A1 (fr) |
| ZA (1) | ZA201000207B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009202819B2 (en) | 2007-07-13 | 2014-08-28 | Aramis Biotechnologies Inc. | Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin |
| CA2615372A1 (fr) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Particules semblables au virus grippal a comprenant de l'hemagglutinine |
| JP5809054B2 (ja) | 2008-07-08 | 2015-11-10 | メディカゴ インコーポレイテッド | 可溶性組換えインフルエンザ抗原 |
| EP2318530B1 (fr) | 2008-07-18 | 2016-06-22 | Medicago Inc. | Nouvel épitope d immunisation contre l'influenzavirus |
| HUE039100T2 (hu) | 2009-06-24 | 2018-12-28 | Medicago Inc | Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék |
| MY158475A (en) | 2009-09-22 | 2016-10-14 | Medicago Inc | Method of preparing plant-derived proteins |
| TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
| US11673926B2 (en) * | 2011-06-07 | 2023-06-13 | Ibio, Inc. | In vivo de-glycosylation of recombinant proteins by co-expression with PNGase F |
| US9181532B2 (en) | 2011-07-29 | 2015-11-10 | Icon Genetics Gmbh | Production of galactosylated N-glycans in plants |
| FI2760882T3 (fi) | 2011-09-30 | 2023-07-17 | Medicago Inc | Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa |
| WO2013169009A1 (fr) * | 2012-05-08 | 2013-11-14 | 경상대학교 산학협력단 | Plante pour la production de n-glycane riche en mannose, et procédé de production de n-glycane riche en mannose à l'aide de celle-ci |
| IL295155A (en) | 2013-03-28 | 2022-09-01 | Medicago Inc | Production of influenza virus-like particles in plants |
| US12467058B2 (en) | 2013-03-28 | 2025-11-11 | Aramis Biotechnologies Inc. | Influenza virus-like particle production in plants |
| ES2787042T3 (es) | 2014-07-11 | 2020-10-14 | Medicago Inc | Modificación de la producción de proteínas en plantas |
| CN107810271B (zh) * | 2014-11-20 | 2021-09-28 | 耶路撒冷希伯来大学伊萨姆研发公司 | 用于在植物细胞中生产具有改变的糖基化模式的多肽的组合物和方法 |
| WO2018098572A1 (fr) | 2016-12-01 | 2018-06-07 | Plantform Corporation | Plante transgénique à activité fucosyltransférase et xylosyltransférase réduite |
| CN111328347A (zh) * | 2017-09-11 | 2020-06-23 | R.J.雷诺兹烟草公司 | 通过与p21共表达来增加植物中感兴趣基因的表达的方法和组合物 |
| JP7566045B2 (ja) * | 2021-01-15 | 2024-10-11 | デンカ株式会社 | 栽培条件を決定する方法、及び目的タンパク質又は目的ペプチドの製造方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312746A (en) * | 1993-01-08 | 1994-05-17 | Life Technologies, Inc. | Cloning and expressing restriction endonucleases and modification methylases from caryophanon |
| GB9524350D0 (en) * | 1995-11-29 | 1996-01-31 | Lynxvale Ltd | Enhancer-increased gene expression in plants |
| US5945326A (en) * | 1997-03-20 | 1999-08-31 | New England Biolabs, Inc. | Method for cloning and producing the Spel restriction endonuclease |
| JP2002543760A (ja) * | 1998-12-09 | 2002-12-24 | 達治 関 | ヒト型糖鎖をもつ糖タンパク質の生産方法 |
| US7125978B1 (en) * | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| WO2001025455A2 (fr) * | 1999-10-04 | 2001-04-12 | Medicago Inc. | Promoteur destine a reguler l'expression de genes etrangers |
| AU1573601A (en) * | 1999-10-21 | 2001-04-30 | Monsanto Company | Post-translational modification of recombinant proteins produced in plants |
| ES2349427T3 (es) * | 1999-10-26 | 2011-01-03 | Stichting Dienst Landbouwkundig Onderzoek | Glicosilación de tipo mamífero en plantas. |
| CA2925231A1 (fr) * | 1999-10-26 | 2001-05-03 | Stichting Dienst Landbouwkundig Onderzoek | Glycosylation de type mammifere dans des plantes transgeniques par l'expression de galactosyltrasferases et de sialyl transferases |
| JP2005505234A (ja) * | 2001-01-19 | 2005-02-24 | ザ ダウ ケミカル カンパニー | 植物細胞によるヒト型糖鎖をもつ糖タンパク質の分泌生産方法 |
| US20030035774A1 (en) | 2001-07-18 | 2003-02-20 | Adjei Akwete L. | Salt/ion pair medicinal aerosol formulation |
| NZ571596A (en) * | 2001-08-03 | 2010-11-26 | Glycart Biotechnology Ag | Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| AU2003219745B8 (en) * | 2002-02-13 | 2008-10-09 | Wisconsin Alumni Research Foundation | Signal for packaging of influenza virus vectors |
| AU2003219418B2 (en) * | 2002-03-19 | 2008-02-28 | Stichting Dienst Landbouwkundig Onderzoek | Optimizing glycan processing in plants |
| JP5350573B2 (ja) * | 2002-03-19 | 2013-11-27 | スティヒティング ディーンスト ランドバウクンディフ オンデルズーク | 植物におけるgntiii発現 |
| PL224787B1 (pl) | 2003-01-22 | 2017-01-31 | Roche Glycart Ag | Wyizolowany kwas nukleinowy, ssaczy wektor ekspresyjny, fuzje polipeptydowe, komórki gospodarza, sposób wytwarzania fuzji polipeptydowych, sposoby in vitro i ex vivo modyfikowania profilu glikozylacji, wyizolowana cząsteczka kwasu nukleinowego |
| CN1761746B (zh) * | 2003-01-22 | 2016-03-23 | 罗氏格黎卡特股份公司 | 融合构建体及其用来生产Fc受体结合亲和性和效应子功能提高的抗体的用途 |
| BRPI0410340A (pt) * | 2003-05-05 | 2006-05-30 | Dow Agrosciences Llc | vetores e células para preparar composições imunoprotetoras derivadas de plantas transgênicas |
| JP2006212019A (ja) * | 2004-04-30 | 2006-08-17 | National Institute Of Agrobiological Sciences | 植物を用いたユビキノン−10の製造方法 |
-
2008
- 2008-06-13 PL PL08772802T patent/PL2155880T3/pl unknown
- 2008-06-13 CA CA2795379A patent/CA2795379A1/fr not_active Abandoned
- 2008-06-13 JP JP2010511461A patent/JP5783720B2/ja not_active Expired - Fee Related
- 2008-06-13 MX MX2009013665A patent/MX2009013665A/es active IP Right Grant
- 2008-06-13 ES ES08772802.8T patent/ES2624776T3/es active Active
- 2008-06-13 US US12/664,567 patent/US20110008837A1/en not_active Abandoned
- 2008-06-13 KR KR1020107000811A patent/KR101385050B1/ko not_active Expired - Fee Related
- 2008-06-13 KR KR1020137014893A patent/KR20130075787A/ko not_active Ceased
- 2008-06-13 WO PCT/CA2008/001139 patent/WO2008151440A1/fr not_active Ceased
- 2008-06-13 CN CN201510364867.XA patent/CN104962579A/zh active Pending
- 2008-06-13 BR BRPI0812538-4A patent/BRPI0812538B1/pt not_active IP Right Cessation
- 2008-06-13 SG SG2012066486A patent/SG185249A1/en unknown
- 2008-06-13 AU AU2008261527A patent/AU2008261527C1/en not_active Ceased
- 2008-06-13 CN CN2008801031743A patent/CN101918559A/zh active Pending
- 2008-06-13 SI SI200831699A patent/SI2155880T1/sl unknown
- 2008-06-13 NZ NZ598417A patent/NZ598417A/xx not_active IP Right Cessation
- 2008-06-13 NZ NZ581944A patent/NZ581944A/en unknown
- 2008-06-13 HU HUE08772802A patent/HUE031698T2/en unknown
- 2008-06-13 CA CA2700180A patent/CA2700180C/fr active Active
- 2008-06-13 EP EP08772802.8A patent/EP2155880B1/fr active Active
- 2008-06-13 CN CN2013101091944A patent/CN103382487A/zh active Pending
- 2008-06-13 PT PT87728028T patent/PT2155880T/pt unknown
- 2008-06-13 RU RU2010101024/10A patent/RU2499053C2/ru active
- 2008-06-13 DK DK08772802.8T patent/DK2155880T3/en active
-
2009
- 2009-12-07 IL IL202568A patent/IL202568A/en active IP Right Grant
- 2009-12-10 TN TNP2009000512A patent/TN2009000512A1/fr unknown
- 2009-12-14 EG EG2009121826A patent/EG26600A/en active
-
2010
- 2010-01-12 ZA ZA2010/00207A patent/ZA201000207B/en unknown
- 2010-01-12 MA MA32504A patent/MA31516B1/fr unknown
-
2013
- 2013-08-08 RU RU2013137208/10A patent/RU2013137208A/ru not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000512A1 (en) | Modifying glycoprotein production in plants | |
| PH12012500816A1 (en) | Modified oil encapsulating proteins and uses thereof | |
| SG10201803982TA (en) | Antibodies and processes for preparing the same | |
| MY160680A (en) | Process for producing molecules containing specialized glycan structures | |
| DE60022313D1 (de) | Alternansucrase-kodierende nukleinsäure moleküle | |
| DE50014279D1 (de) | Nukleinsäuremoleküle aus pflanzen codierend enzyme, die an der stärkesynthese beteiligt sind | |
| AR048024A1 (es) | Plantas con actividad aumentada de distintas enzimas fosforilantes del almidon | |
| MX2009009371A (es) | Produccion mejorada de derivados de acidos grasos. | |
| MX2009011751A (es) | Produccion de proteinas de alto contenido de manosa en cultivo de plantas. | |
| WO2008132314A3 (fr) | Procede de synthese de nanoparticules metalliques cubiques en presence de deux reducteurs | |
| DK1725666T3 (da) | Planter med reduceret aktivitet for stivelsesphosphoryleringsenzymet phosphoglucan-vand-dikinase | |
| WO2011100477A3 (fr) | Anticorps et procédés de préparation de ceux-ci | |
| CY1109471T1 (el) | Μεθοδοι και μεσα για την παραγωγη υαλουρονανης | |
| WO2009080743A3 (fr) | Plantes à rendement accru (ko nue) | |
| WO2010066411A3 (fr) | Polypeptides à activité de cellobiohydrolase ii | |
| MX2009010867A (es) | Plantas con caracteristicas de crecimientos mejoradas en condiciones de disponibilidad reducida de nutrientes y un metodo para producirlas. | |
| IN2012DN01454A (fr) | ||
| EP2162537A4 (fr) | Utilisation d'organismes genetiquement modifies pour generer des enzymes de decomposition de biomasse | |
| WO2006079546A3 (fr) | Production de protéines hétéro-oligomères dans des plantes | |
| WO2007134268A3 (fr) | Production de biohydrogène par voie enzymatique artificielle | |
| GB2458419A (en) | Vector for expressing NC protein of HIV and method for producing NC protein using the same | |
| WO2008033556A3 (fr) | Traitement de protéines sous haute pression permettant de réduire leur immunogénicité | |
| WO2007140340A3 (fr) | Formation de réseaux vasculaires à l'aide de cellules souches embryonnaires | |
| WO2009137146A3 (fr) | Procédé de production de lignées cellulaires continues | |
| PL1861504T3 (pl) | Glikoinżynieria grzybów |